Medix Infusion, a leader in the infusion industry, announced that Pavlos "Pav" Pavlidis has been appointed Medix's new President and Chief Operating Officer.
ADDISON, Texas, Jan. 29, 2024 /PRNewswire-PRWeb/ -- As Medix Infusion's new President and COO, Pav will lead and scale the company's multi-state business operations including Nursing, Pharmacy, Procurement, Business Insights and other operational departments that support the Company's 40 locations across 5 states. Since the end of 2020 Medix has grown nearly 600%, expanded manufacturer partnerships and established itself as a leader in infusion care. "Pav brings decades of leadership and operations experience in specialty pharmacy, biotechnology, and patient support services, as well as exceptional physician and patient advocacy focus. Execution without compromising, our team culture will be essential as Medix looks to continue to grow as a national leader, and Pav has an impressive history of developing efficiencies while developing, coaching, and successfully impacting organizational culture. We are delighted to have someone of Pav's caliber and reputation join our mission, and we look forward to his contributions in the next phase of the Company's growth," said CEO Gus de Avillez.
Prior to joining Medix Infusion, Pav served as Chief Operating Officer at Biologics by McKesson. Pav had many other notable leadership roles, including President & Chief Operating Officer at AppianRx, VP at UnitedHealth Group, Sr. Director at Biogen, VP and General Manager at Medco. Pav holds a B.S. in Pharmacy from Ohio State University and is a Registered Pharmacist.
About Medix Infusion
Medix Infusion provides best-in-class infusion care. The company's mission is to connect chronically ill and high-acuity patients with infusion therapy by providing convenient, compassionate care within rural, suburban, and other under-served markets. Headquartered in Addison, TX, the company manages suites across Texas, Arizona, Oregon, Kansas, and Missouri, with expansion underway in several other states. Information about the company is also available at www.medixinfusion.com. The company is backed by Noro-Moseley Partners (https://noromoseley.com) and Echo Health Ventures (https://www.echohealthventures.com).
For more information, press only:
Gus de Avillez
SOURCE Medix Infusion